Strain | Genetic background | Fermentation condition | Ethanol yield (g/g) | |
---|---|---|---|---|
XUSE (this study) | xylA3*, TAL1, XKS1, Δgre3, Δpho13, evolved | Microaerobic batch in serum bottle, synthetic medium (20 g/L xylose) | OD 0.2 | 0.43 |
OD 2 | 0.45 | |||
OD 10 | 0.4 | |||
SXA-R2P-E | xylA3*, tal1, XKS1, Δgre3, Δpho13, evolved | Microaerobic batch in serum bottle, synthetic medium (20 g/L xylose) | OD 0.2 | 0.4 |
OD 2 | 0.4 | |||
OD 10 | 0.4 | |||
Anaerobic batch in bioreactor, synthetic medium (40Â g/L xylose) | Â | 0.45 [15] | ||
RWB217 | xylA, TAL1, TKL1, RPE1, RKI1, Δgre3 | Anaerobic batch in fermenter, synthetic medium (20 g/L xylose) |  | 0.43 [14] |
H131-A3-ALCS | xylA, xyl3, TAL1, TKL1, RPE1, RKI1, evolved | Anaerobic batch in bioreactor, synthetic medium (40Â g/L xylose) | Â | 0.41 [13] |
TMB 3424 | xyl1, xyl2, XKS1, TKL1, RPE1, RKI1, ∆gre3, evolved | Anaerobic batch in bioreactor, synthetic medium (60 g/L xylose) |  | 0.36 [12] |